Login to your account

Username *
Password *
Remember Me
Bibliographie

Bibliographie (2530)

Large cohort study finds one in two hospitalized COVID-19 patients develop a complication.

lundi, 26 juillet 2021 09:29 Écrit par

Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study – The Lancet Commentaries: Landmark study finds one in two hospitalised COVID-19 patients develop a complication – National Institute for Health Research In-hospital complications associated with COVID-19 – The Lancet CV Complications Common in Hospitalized […]

The post Large cohort study finds one in two hospitalized COVID-19 patients develop a complication. appeared first on Links Medicus.

Position paper: Advancing precision medicine for acute respiratory distress syndrome.

lundi, 26 juillet 2021 04:44 Écrit par

Advancing precision medicine for acute respiratory distress syndrome – The Lancet Respiratory Medicine Related: Review: Personalized mechanical ventilation in acute respiratory distress syndrome. Seminar | Acute respiratory distress syndrome. M-A of randomized trials: In patients with acute respiratory distress syndrome, there was no difference in mortality between higher vs. lower positive end-expiratory pressure strategies. M-A: […]

The post Position paper: Advancing precision medicine for acute respiratory distress syndrome. appeared first on Links Medicus.

Review: Ethics in extracorporeal life support.

vendredi, 23 juillet 2021 14:00 Écrit par

Ethics in extracorporeal life support: a narrative review – Critical Care  

The post Review: Ethics in extracorporeal life support. appeared first on Links Medicus.

What are the Delta, Gamma, Beta and Alpha Covid variants?

vendredi, 23 juillet 2021 14:00 Écrit par

Related: Increased transmissibility and global spread of SARS-CoV-2 variants of concern – “Estimated transmissibility increases of alpha 29% (95% CI: 24–33), beta 25% (95% CI: 20–30), gamma 38% (95% CI: 29–48) & delta 97% (95% CI: 76–117)”. AND WHO renames COVID-19 variants with the Greek alphabet (i.e., Alpha, Beta, Gamma, etc), making them simple, easy […]

The post What are the Delta, Gamma, Beta and Alpha Covid variants? appeared first on Links Medicus.

Opinion | Tocilizumab in COVID-19 therapy: who benefits, and how? – the researchers suggest that maybe IL-6 inhibitors should be given only to patients with high IL-6.

vendredi, 23 juillet 2021 14:00 Écrit par

Tocilizumab in COVID-19 therapy: who benefits, and how? – The Lancet Related: A living WHO guideline on drugs for covid-19 – interleukin-6 receptor blockers are now recommended for patients with severe or critical covid-19. AND M-A: Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 – “The 4% absolute risk reduction […]

The post Opinion | Tocilizumab in COVID-19 therapy: who benefits, and how? – the researchers suggest that maybe IL-6 inhibitors should be given only to patients with high IL-6. appeared first on Links Medicus.

Review: Personalized mechanical ventilation in acute respiratory distress syndrome.

jeudi, 22 juillet 2021 14:00 Écrit par

Personalized mechanical ventilation in acute respiratory distress syndrome – Critical Care Related: M-A of randomized trials: In patients with acute respiratory distress syndrome, there was no difference in mortality between higher vs. lower positive end-expiratory pressure strategies. AND Seminar | Acute respiratory distress syndrome. AND Short review: Diagnosis and management of acute respiratory distress syndrome […]

The post Review: Personalized mechanical ventilation in acute respiratory distress syndrome. appeared first on Links Medicus.

COVID-19 antibodies persist at least nine months after infection – “98.8 percent of people infected in February/March showed detectable levels of antibodies in November”.

jeudi, 22 juillet 2021 14:00 Écrit par

News release: COVID-19 antibodies persist at least nine months after infection – Imperial College London Original study: SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’ – Nature Communications  

The post COVID-19 antibodies persist at least nine months after infection – “98.8 percent of people infected in February/March showed detectable levels of antibodies in November”. appeared first on Links Medicus.

RCT: Dapagliflozin in patients with cardiometabolic risk factors hospitalized with COVID-19 – safe, but no statistically significant risk reduction in organ dysfunction or death.

jeudi, 22 juillet 2021 14:00 Écrit par

Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial – The Lancet Diabetes & Endocrinology Commentary: Dapagliflozin in patients with COVID-19: truth or dare – The Lancet Diabetes & Endocrinology  

The post RCT: Dapagliflozin in patients with cardiometabolic risk factors hospitalized with COVID-19 – safe, but no statistically significant risk reduction in organ dysfunction or death. appeared first on Links Medicus.

Study shows AstraZeneca and Pfizer vaccines are effective against Delta variant, but both doses are needed.

jeudi, 22 juillet 2021 14:00 Écrit par

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant – New England Journal of Medicine Commentaries: Study Finds Pfizer And AstraZeneca Vaccines Effective Against The Delta Variant — As Long As You Get Both Doses – Forbes AND Pfizer’s COVID-19 vaccine works very well against the Delta variant — but only after 2 doses – […]

The post Study shows AstraZeneca and Pfizer vaccines are effective against Delta variant, but both doses are needed. appeared first on Links Medicus.